- Home
- NRBO vs SOHO Comparison
NRBO vs SOHO Comparison
Compare NRBO & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRBO
- SOHO
- Stock Information
- Founded
- NRBO N/A
- SOHO 2004
- Country
- NRBO United States
- SOHO United States
- Employees
- NRBO N/A
- SOHO N/A
- Industry
- NRBO Biotechnology: Pharmaceutical Preparations
- SOHO Real Estate Investment Trusts
- Sector
- NRBO Health Care
- SOHO Real Estate
- Exchange
- NRBO Nasdaq
- SOHO Nasdaq
- Market Cap
- NRBO 27.9M
- SOHO 27.2M
- IPO Year
- NRBO N/A
- SOHO 2004
- Fundamental
- Price
- NRBO $2.36
- SOHO $1.02
- Analyst Decision
- NRBO Strong Buy
- SOHO Hold
- Analyst Count
- NRBO 1
- SOHO 1
- Target Price
- NRBO $10.00
- SOHO $1.50
- AVG Volume (30 Days)
- NRBO 36.9K
- SOHO 128.4K
- Earning Date
- NRBO 11-07-2024
- SOHO 11-12-2024
- Dividend Yield
- NRBO N/A
- SOHO N/A
- EPS Growth
- NRBO N/A
- SOHO N/A
- EPS
- NRBO N/A
- SOHO N/A
- Revenue
- NRBO N/A
- SOHO $179,860,606.00
- Revenue This Year
- NRBO N/A
- SOHO N/A
- Revenue Next Year
- NRBO N/A
- SOHO $0.70
- P/E Ratio
- NRBO N/A
- SOHO N/A
- Revenue Growth
- NRBO N/A
- SOHO 3.98
- 52 Week Low
- NRBO $2.08
- SOHO $0.97
- 52 Week High
- NRBO $6.75
- SOHO $1.65
- Technical
- Relative Strength Index (RSI)
- NRBO 40.83
- SOHO 38.38
- Support Level
- NRBO $2.30
- SOHO $1.02
- Resistance Level
- NRBO $2.50
- SOHO $1.09
- Average True Range (ATR)
- NRBO 0.23
- SOHO 0.06
- MACD
- NRBO -0.01
- SOHO -0.02
- Stochastic Oscillator
- NRBO 24.75
- SOHO 12.12
About NRBO NeuroBo Pharmaceuticals Inc.
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.